M. Beller, H. Trauthwein, M. Eichberger, C. Breindl, T. E. Müller
FULL PAPER
yield: 65% (586 mg). Ϫ 1H NMR (360 MHz, 25°C, CDCl3): δ ϭ
Reaction of 4-Vinylpyridine with Morpholine: In a procedure anal-
3
8.42 [d, J(H,H) ϭ 5.8 Hz, 1 H, 6-H], 7.50 (m, 1 H, 4-H), 7.08 (m, ogous to the synthesis of 1, 0.38 mL of morpholine (4.40 mmol)
1 H, 3-H), 7.00 (m, 1 H, 5-H), 2.94 (m, 2 H, PyϪCH2ϪCH2), 2.70 and 1.90 mL of 4-vinylpyridine (17.6 mmol) in 10 mL of THF were
(m, 2 H, PyϪCH2), 2.54 (s, br., 4 H, NϪCH2), 2.48 (s, br., 4 H, treated in the presence of 45 mg of [Rh(cod)2]BF4 (0.11 mmol) and
NϪCH2), 2.21 (s, 3 H, NϪCH3). Ϫ 13C{1H} NMR (91 MHz, 58 mg of PPh3 (0.22 mmol).
25°C, CDCl3): δ ϭ 160.2 (C-2), 149.1 (C-6), 136.2 (C-4), 123.0 (C-
N-[2-(4-Pyridyl)ethyl]morpholine (11): GC yield: 54%; isolated
3), 121.0 (C-5), 58.2 (PyϪCϪC), 54.9 (CH2ϪN), 52.9 (CH2ϪN),
yield: 44% (37 mg). Ϫ 1H NMR (360 MHz, 25°C, CDCl3): δ ϭ
45.9 (NϪCH3), 35.7 (PyϪC). Ϫ MS; m/z: 205 [Mϩ], 161 [Mϩ
Ϫ
3
3
8.28 [d, J(H,H) ϭ 4.5 Hz, 2 H, H-2], 7.01 [d, J(H,H) ϭ 4.5 Hz,
C2H6N], 149 [Mϩ
Ϫ Ϫ C4H8N], 106
C3H6N], 135 [Mϩ
3
2 H, 3-H], 3.60 [t, J(H,H) ϭ 4.4 Hz, 4 H, CH2ϪO], 2.67 (m, 2 H,
[C5H4NϪC2H4ϩ].
PyϪCH2ϪCH2), 2.51 (m, 2 H, PyϪCH2), 2.40 [t, 3J(H,H) ϭ
4.4 Hz, 4 H, CH2N]. Ϫ 13C{1H} NMR (91 MHz, 25°C, CDCl3):
δ ϭ 149.5 (C-2), 149.1 (C-4), 124.0 (C-3), 66.7 (CϪO), 59.1
(PyϪCϪC), 53.4 (CϪN), 32.4 (PyϪC). Ϫ MS; m/z: 192 [M Ϫ Hϩ],
132, 106 [C5H4NϪC2H4ϩ], 100 [CH2ϭN(CH2)4Oϩ].
Reaction of 2-Vinylpyridine with NЈ-Phenylpiperazine: In a pro-
cedure analogous to the synthesis of 1, 0.67 mL of N-phenylpipera-
zine (4.40 mmol) and 1.90 mL of 2-vinylpyridine (17.6 mmol) in 10
mL of THF were treated in the presence of 45 mg of [Rh(cod)2]BF4
(0.11 mmol) and 58 mg of PPh3 (0.22 mmol).
[(1,2,5,6-η)-1,5-Cyclooctadiene]bis[N-(2-vinylpyridine)]rhodium(I)
Tetrafluoroborate (12): 100 mg of [Rh(cod)Cl]2 (0.20 mmol) and
80 mg of AgBF4 (0.41 mmol) were dissolved in 2 mL of THF and
the solution was stirred for 10 min. After filtering off the AgCl
precipitate, the orange solution was cooled to 0°C and 94 mg of 2-
vinylpyridine (0.90 mmol) was added. After stirring the reaction
mixture for several minutes, a yellow precipitate was obtained.
(E)-N-[2-(2-Pyridyl)ethenyl]-NЈ-phenylpiperazine (8a): GC yield:
8%. Ϫ MS; m/z: 265 [Mϩ], 207 [Mϩ Ϫ C3H8N], 160 [Mϩ
C5H4NϪC2H3], 120 [C5H4NϪC2H4Nϩ], 104 [C5H4NϪC2H2ϩ].
Ϫ
N-[2-(2-Pyridyl)ethyl]-NЈ-phenylpiperazine (8b): GC yield (before
hydrogenation): 91%; GC yield (after hydrogenation): 99%; isolated
1
yield: 88% (1033 mg). Ϫ H NMR (360 MHz, 25°C, CDCl3): δ ϭ
3
3
8.52 [d, J(H,H) ϭ 5.9 Hz, 1 H, 6-H], 7.60 [dt, J(H,H) ϭ 7.7 Hz, After filtration, the crude product was washed three times with 1
4J(H,H) ϭ 1.7 Hz, 1 H, 4-H], 7.26 (m, 3 H, 3-H, H-8), 7.12 (m, 1 mL of THF and three times with pentane. Drying in vacuo fur-
H, H-10), 6.99 (m, 3 H, 5-H, H-9), 3.28 [t, 3J(H,H) ϭ 4.7 Hz, 4 H, nished 154 mg of 12 (76%). Ϫ 1H NMR (400 MHz, CDCl3, 20°C):
CH2ϪN], 3.10 (m, 2 H, PyϪCH2ϪCH2), 2.94 (m, 2 H, PyϪCH2),
δ ϭ 8.92 (s, br., 1 H, 6-H), 8.71 (s, br., 1 H, H-7), 7.66 [t, 3J(H,H) ϭ
3
2.79 [t, 3J(H,H) ϭ 4.7 Hz, 4 H, CH2ϪN]. Ϫ 13C{1H} NMR 7.9 Hz, 1 H, 4-H], 7.55 [d, J(H,H) ϭ 7.9 Hz, 1 H, 3-H], 7.32 (s, 1
3
(91 MHz, 25°C, CDCl3): δ ϭ 160.2 (C-2), 151.2 (C-7), 149.1 (C-
6), 136.3 (C-4), 129.0 (C-9), 123.2 (C-3), 121.2 (C-5), 119.7 (C-
10), 116.0 (C-8), 58.3 (PyϪCϪC), 53.1 (CϪN), 52.9 (CϪN), 35.7
H, 5-H), 6.05 [d, br., J(H,H) ϭ 17.6 Hz, 2 H, H-8], 4.17 [s, br., 2
H, CH (cod)], 3.90 [s, br., 2 H, CH (cod)], 2.81 [s, br., 2 H, CH2
(cod)], 2.64 [s, br., 2 H, CH2 (cod)], 2.10 [s, br., 2 H, CH2 (cod)],
(PyϪC). Ϫ MS; m/z: 267 [Mϩ], 175 [C6H5ϪN(C4H8NCH2)ϩ], 161 1.84 [s, br., 2 H, CH2 (cod)]. Ϫ 13C NMR (100 MHz, CDCl3,
[C6H5ϪN(C4H8N)ϩ],
[C5H4NϪC2H4NCH3ϩ],
[C5H4NϪC2H4ϩ].
148
[C5H4NϪC2H4N(CH2)2ϩ],
120
[C5H4NϪC2H4Nϩ],
135 20°C): δ ϭ 157.1 (C-2), 151.0 (C-6), 138.2 (C-8), 135.7 (C-4), 124.4
106 (C-5), 123.0 (C-7), 121.8 (C-3), 85.4 [CH (cod)], 83.9 [CH (cod)],
1
31.5 [CH2 (cod)], 29.6 [CH2 (cod)]. Ϫ At Ϫ60°C, in both the H-
NMR and the 13C-NMR spectra, a second set of weak resonances
Reaction of 4-Vinylpyridine with Piperidine: In a procedure anal-
ogous to the synthesis of 1, 0.44 mL of piperidine (4.40 mmol) and
1.90 mL of 4-vinylpyridine (17.6 mmol) in 10 mL of THF were
treated in the presence of 45 mg of [Rh(cod)2]BF4 (0.11 mmol) and
58 mg of PPh3 (0.22 mmol).
(w) appears, which has only 1/10 of the intensity of the main one
1
(ss): H NMR (400 MHz, CDCl3, Ϫ60°C): δ ϭ 9.43 (w, m, 1 H),
3
3
8.92 [ss, d, J(H,H) ϭ 4.4 Hz, 1 H, 6-H], 8.74 [ss, dd, J(H,H) ϭ
11.0 Hz, 3J(H,H) ϭ 17.0 Hz, 1 H, H-7], 8.08 [w, dd, 3J(H,H) ϭ
11.0 Hz, 3J(H,H) ϭ 17.0 Hz], 7.66 [ss, t, 3J(H,H) ϭ 7.9 Hz, 1 H,
3
N-[2-(4-Pyridyl)ethyl]piperidine (9): GC yield: 57%; isolated yield:
36% (301 mg). Ϫ 1H NMR (360 MHz, 25°C, CDCl3): δ ϭ 8.34 [d,
4-H], 7.55 [ss, d, J(H,H) ϭ 8.0 Hz, 1 H, 3-H], 7.42 (w, m, 1 H),
7.28 (ss, m, 1 H, 5-H), 6.09 [ss, dd, br., 3J(H,H) ϭ 17.6 Hz,
3J(H,H) ϭ 11.0 Hz, 2 H, H-8], 6.00 (w, m, 1 H), 5.89 [w, d,
3J(H,H) ϭ 11.0 Hz], 4.16 [ss, m, 2 H, CH (cod)], 4.06 (w, s, 1 H),
3.93 (w, s, 1 H), 3.83 [ss, m, 2 H, CH (cod)], 2.84 [ss, m, 2 H, CH2
(cod)], 2.64 [ss, m, br., 2 H, CH2 (cod)], 2.17 [ss, m, 2 H, CH2
(cod)], 1.97 (w, m, 1 H), 1.82 (w, m, 1 H), 1.84 [ss, br., 2 H, CH2
(cod)]. Ϫ 13C NMR (100 MHz, CDCl3, Ϫ60°C): δ ϭ 157.1 (ss, C-
2), 156.0 (w, C-2), 151.1 (ss, C-6), 150.6 (w, C-6), 138.4 (ss, C-8),
138.1 (w, C-8), 136.5 (w, C-4), 135.6 (ss, C-4), 124.7 (w, C-5), 124.5
(ss, C-5), 123.5 (ss, C-7), 122.3 (w, C-7), 122.0 (ss, C-3), 121.6 (w,
C-3), 88.2 [w, d, 1J(C,Rh) ϭ 11.7 Hz, CH (cod)], 85.2 [ss, d,
1J(C,Rh) ϭ 11.7 Hz, CH (cod)], 84.9 [ss, d, 1J(C,Rh) ϭ 11.7 Hz,
CH (cod)], 81.2 [w, d, 1J(C,Rh) ϭ 11.7 Hz, CH (cod)], 32.1 [ss,
CH2 (cod)], 30.6 [w, CH2 (cod)], 30.4 [w, CH2 (cod)], 29.1 [ss, CH2
(cod)]. Ϫ C22H26BF4N2Rh (508.17): calcd. C 52.0, H 5.2, N 5.5;
found C 51.8, H 5.3, N 5.4.
3
3J(H,H) ϭ 4.9 Hz, 2 H, H-2], 7.01 [d, J(H,H) ϭ 4.9 Hz, 2 H, 3-
H], 2.65 (m,
2 H, PyϪCH2ϪCH2ϪN), 2.44 (m, 2 H,
PyϪCH2ϪCH2ϪN), 2.37 (m, 4 H, NϪCH2), 1.47 (m, 4 H,
NϪCH2ϪCH2), 1.31 (m, 2 H, NϪCH2ϪCH2ϪCH2). Ϫ 13C{1H}
NMR (91 MHz, 25°C, CDCl3): δ ϭ 149.6 (C-2), 149.6 (C-4), 124.1
(C-3), 59.8 (PyϪCϪCϪN), 54.4 (CϪN), 32.9 (PyϪC), 25.9
(NϪCϪC), 24.3 (NϪCϪCϪC). Ϫ MS; m/z: 190 [M Ϫ Hϩ], 105
[C5H4NϪC2H3ϩ], 98 [CH2ϭN(CH2)5ϩ].
Reaction of 4-Vinylpyridine with Hexahydroazepine: In a procedure
analogous to the synthesis of 1, 0.50 mL of hexahydroazepine
(4.40 mmol) and 1.90 mL of 4-vinylpyridine (17.6 mmol) in 10 mL
of THF were treated in the presence of 45 mg of [Rh(cod)2]BF4
(0.11 mmol) and 58 mg of PPh3 (0.22 mmol).
N-[2-(4-Pyridyl)ethyl]hexahydroazepine (10): GC yield: 21%; iso-
1
lated yield: 13% (116 mg). Ϫ H NMR (360 MHz, 25°C, CDCl3):
δ ϭ 8.40 [d, 3J(H,H) ϭ 4.9 Hz, 2 H, H-2], 7.05 [d, 3J(H,H) ϭ Crystal Data and Structure Refinement of 12: Crystals were grown
4.9 Hz, 2 H, 3-H], 2.71 (m, 8 H, PyϪCH2ϪCH2ϪNϪCH2), 1.17 by slow diffusion of Et2O into a solution of [Rh(cod)(2-vinylpyri-
(m, 8 H, NϪCH2ϪCH2ϪCH2). Ϫ 13C{1H} NMR (91 MHz, 25°C, dine)2]CF3SO3 in CH2Cl2. A yellow crystal of dimensions 0.35 ϫ
CDCl3):
δ
ϭ
149.7 (C-2), 149.6 (C-4), 124.3 (C-3), 58.9
0.30 ϫ 0.17 mm was mounted by the Lindeman technique. Cell
(PyϪCϪCϪN), 54.4 (CϪN), 33.4 (PyϪC), 27.9 (NϪCϪC), 27.0 constants were determined by least-squares refinement of 5000 re-
(NϪCϪCϪC). Ϫ MS; m/z: 203 [Mϩ], 112 [C6H12NCH2ϩ].
flections in the intervall 16.8° < 2Θ < 49.8° with the program
1130
Eur. J. Inorg. Chem. 1999, 1121Ϫ1132